Search results
Novo Nordisk Dips After Wegovy Sales Double, But Miss Analysts' Forecast
Investor's Business Daily· 6 hours agoOn today's stock market, Novo Nordisk stock toppled 4% to 124.02. The MarketSurge stock chart shows...
These Are The 5 Best Stocks To Buy And Watch Now
Investor's Business Daily· 7 hours agoBuying a stock is easy, but buying the right stock without a time-tested strategy is incredibly hard. So which are the best stocks to buy now or put on a...
Analysts reveal Eli Lilly stock price targets after earnings
TheStreet.com· 3 hours agoHere's what could happen next to Eli Lilly shares. The people at Eli Lilly (LLY) say they're working as fast as they can. Mounjaro and Zepbound are the same drug, tirzepatide, but they are marketed ...
Novo Nordisk Dips As Q1 Wegovy Sales Double, But Miss Target
Investor's Business Daily· 14 hours agoNovo Nordisk stock came under mild selling pressure early Thursday, after the company reported Q1...
Morning Bid: Fed QT taper calms the horses, yen pops again
Reuters· 16 hours agoAnxious bond traders seem to have taken solace from the Federal Reserve's surprisingly sharp brake...
Can biotech startups upstage Eli Lilly and Novo Nordisk?
The Economist· 2 days agoAn index of American big pharma rose by a third, outperforming the broader stockmarket thanks to...
DexCom (DXCM) Q1 Earnings Beat, Strong CGM Demand Continues
Zacks via Yahoo Finance· 7 days agoDexCom's (DXCM) first-quarter 2024 results reflect strong domestic and international revenue growth...
Eli Lilly assures investors it can overcome the high-quality problem of too much demand
CNBC· 2 days agoThe numbers leave little doubt that the long-term Eli Lilly success story remains intact, as demand for its new diabetes and obesity drugs, Mounjaro and Zepbound, outstrips ...
The Science of Sleep. How the Travel Industry is Cashing in on Tourism’s Latest Obsession
Skift· 4 days agoA recent Gallup poll found a majority of U.S. adults – and especially women under age 50 – say they...
Lilly Is Expensive, But Priced for Explosive Growth: How to Trade It
TheStreet.com· 2 days agoThe company is stingy with information, although sales growth and margins are going in the right...